Tracking

Why Your Migraine Comes Back After the Medication Works

Two different things get called rebound: a drug clearing before the attack ends, or a pattern that builds over months. Telling them apart changes what to do.

A woman lying on a bed with her eyes closed and one hand resting against her forehead, wearing a pale yellow sweatshirt against white pillows.

If the medication worked and the headache returned the same evening or as you woke the next morning, that is recurrence: the drug cleared your system before the attack had finished running. It concerns one attack.

If your headaches have slowly become more frequent over months while you have been treating them often, that is a different thing entirely — medication-overuse headache, which is a pattern, not an event.

Both get called “rebound” in everyday use. They are on completely different timescales and the sensible responses point in opposite directions, so it is worth being clear which one you are looking at.

The mechanism: your attack outlasts the drug

An untreated migraine attack runs anywhere from four to seventy-two hours — that range is part of the diagnostic definition of migraine itself. An oral sumatriptan tablet has an elimination half-life of about two and a half hours, per its FDA label.

Put those two numbers next to each other and recurrence stops being mysterious. The tablet does not end the attack — it suppresses the pain while there is enough of it in your blood. If the underlying attack was going to last thirty hours and the drug is largely gone in ten, the pain has somewhere to come back to.

This is why recurrence is common rather than a sign something has gone wrong. In Tfelt-Hansen and colleagues’ comparative review of the triptans, headache returned within 24 hours of an initially successful response in 30 to 40% of sumatriptan-treated patients.

What makes it more likely

A short-acting drug against a long attack. The triptans differ enormously here. In the same review, sumatriptan’s half-life is around two hours, naratriptan’s five to six, and frovatriptan’s twenty-six to thirty.

The obvious inference is that the long-acting ones must recur less. That is where the evidence gets less tidy than the mechanism suggests. Frovatriptan does show lower 24-hour recurrence, and naratriptan has some advantage, but across the newer triptans as a group the authors found no consistent difference from sumatriptan. The longer-acting ones are also slower to take effect, so a drug that covers a two-day attack better may be the wrong drug for one that arrives fast. Which side of that suits you is a prescriber’s question, and worth raising with your own numbers in hand rather than settling from a half-life table.

Treating late. The same delay that makes a drug less likely to work at all makes recurrence more likely when it does work. That timing variable is also the one that makes a working drug look useless in your own records, which is why judging whether a migraine medication is working means writing down the pain level at the moment you dose, not just the peak.

Long attacks generally. If your untreated attacks habitually run two days, a single dose of anything short-acting was never going to cover it.

Why the distinction matters more than it sounds

The obvious response to recurrence is to take another dose. Sometimes that is exactly right, and most acute drugs have a second dose built into their labelling.

The trap is what happens when it becomes the standing answer. An attack that reliably needs two or three doses across two days, several times a month, is how a person arrives at fifteen or more medication days a month without ever feeling like they are overusing anything. Each individual decision was reasonable. The pattern is the problem.

So recurrence handled by simply taking more, more often, is one of the well-trodden routes into medication overuse. That is the reason to name which of the two you have rather than treating “it came back” as one undifferentiated complaint.

How to tell them apart

Count, over a month:

  • Recurrence shows up inside a single attack. You responded, then the same attack resurfaced within about a day. Your total headache days may be entirely normal.
  • Medication-overuse headache requires headache on fifteen or more days a month, sustained over more than three months, alongside frequent acute treatment. It is a slow change in your baseline, not an event you can point at.

The two can coexist, which is precisely why the day count is worth having in front of you rather than estimating.

Migraine Journal records each dose against the attack it belonged to, so a second dose on the same day shows up as two doses on one day — and its thirty-day medication count treats that as a single medication day, which is the same way the diagnostic criteria count. That distinction is the one that tells you whether you have a recurrence pattern or a frequency pattern.

What to record

Add two fields to whatever you already keep:

  • Did it come back within 24 hours? Yes or no, per attack.
  • How many doses did that attack take in total?

After a month or two those two columns answer the question on their own. Four attacks that each needed three doses is a very different picture from twelve separate single-dose days, even though both total twelve doses — and only one of them is a recurrence problem.

Taking it further

If recurrence is the pattern, there are real options and they are specific: a longer-acting triptan, an anti-inflammatory alongside the triptan rather than after it, or a different class of acute treatment. Combination products exist precisely because the pairing reduces recurrence compared with a triptan alone.

If the frequency is the pattern, better rescue medication is not the answer — preventive treatment is the conversation, because the goal becomes having fewer attacks rather than treating each one twice.

Both of those are prescribing decisions. What you can bring is the distinction, with the count behind it: “my attacks respond and then come back within a day, and it is taking two or three doses each time.” That sentence points a clinician straight at the right half of the problem, and it belongs on the page you take in — what to bring to a neurologist appointment covers the rest of it. The other tracking guides cover the record that produces that count.


This is background reading, not medical advice, and nothing here is a recommendation to take an extra dose of anything. Second doses, switching drugs and combining them are decisions for whoever prescribes for you. If your headaches have changed pattern, or one comes on suddenly and severely, that needs a doctor rather than a diary.

Quick answers

Why does a migraine come back after the medication works?

The drug usually clears before the attack finishes. An untreated attack can run four to seventy-two hours, while oral sumatriptan has an elimination half-life of about two and a half hours, so the pain has somewhere to return to.

How common is migraine recurrence?

Common enough to be expected rather than a sign something is wrong. A comparative review of the triptans found headache returned within 24 hours of an initially successful response in 30 to 40% of sumatriptan-treated patients.

Is recurrence the same as rebound or medication-overuse headache?

No, though both get called rebound. Recurrence happens inside one attack, within about a day. Medication-overuse headache is a slow change in baseline needing headache on fifteen or more days a month for over three months alongside frequent acute treatment.

What should you record to tell the two apart?

Two fields per attack: whether it came back within 24 hours, and how many doses that attack took in total. Four attacks needing three doses each is a recurrence pattern; twelve single-dose days is a frequency pattern, even though both total twelve doses.

Track it in under a minute

Logs an attack in seconds, records the barometric-pressure change automatically, and prints the summary a neurologist asks for.

Download freeiPhone · free to track

This article is general information, not medical advice. Talk to your GP or neurologist about your own symptoms, medication, and treatment.

Keep reading

All posts